Preview Mode Links will not work in preview mode
  1. All Episodes
  2. Cost-Effectiveness of Aducanumab

Cost-Effectiveness of Aducanumab

Sep 1, 2021

Dr. Brian Callaghan discusses the AAN’s comments at a recent ICER meeting on the cost-effectiveness of aducanumab, the newly approved drug for Alzheimer’s disease.